Preliminary results of a phase II trial of proton radiotherapy for pediatric rhabdomyosarcoma

Journal of Clinical Oncology

Volumn 32, Issue 33, 2014, Pages 3762-3770

  Ladra, Matthew M ^a   Szymonifka, Jackie D ^a   Mahajan, Anita ^c   Friedmann, Alison M ^a   Yeap, Beow Yong ^a   Goebel, Claire P ^a   MacDonald, Shannon M ^a   Grosshans, David R ^c   Rodriguez Galindo, Carlos ^b   Marcus, Karen J ^b   Tarbell, Nancy J ^a   Yock, Torunn I ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DACTINOMYCIN; IFOSFAMIDE; TOPOTECAN; VINCRISTINE; PROTON;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CATARACT; CHILD; CHILDHOOD CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EMBRYONAL RHABDOMYOSARCOMA; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HORMONE DEFICIENCY; HUMAN; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MUSCLE ATROPHY; ORBIT TUMOR; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PRESCHOOL CHILD; PROSPECTIVE STUDY; PROTON THERAPY; RADIATION DERMATITIS; RADIATION DOSE; RADIATION INJURY; RELATIVE BIOLOGIC EFFECTIVENESS; RETINOPATHY; SCHOOL CHILD; TIME TO TREATMENT; TREATMENT FAILURE; TUMOR LOCALIZATION; TUMOR VOLUME; UNILATERAL HEARING LOSS; WEIGHT REDUCTION; CLINICAL TRIAL; INFANT; MORTALITY; RANDOMIZED CONTROLLED TRIAL; RHABDOMYOSARCOMA;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; PROSPECTIVE STUDIES; PROTONS; RHABDOMYOSARCOMA;

EID: 84911369075     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.56.1548     Document Type: Article

References (31)

1. Ries L.A.G, Smith M.A., Gurney JG, et al: (eds): Cancer Incidence and Survival Among Children and Adolescents. United States SEER program 1975-1995, National Cancer Institute, SEER Program. NIH Pub. No. 99-4649. Bethesda, MD, 1999
2. Arndt CA, Stoner JA, Hawkins DS, et al: Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: Children's Oncology Group study D9803. J Clin Oncol 27:5182-5188, 2009
3. Raney RB, Walterhouse DO, Meza JL, et al: Results of the Intergroup Rhabdomyosarcoma Study Group D9602 protocol, using vincristine and dactinomycin with or without cyclophosphamide and radiation therapy, for newly diagnosed patients with low-risk embryonal rhabdomyosarcoma: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. J Clin Oncol 29: 1312-1318, 2011
4. Merks JH, De Salvo GL, Bergeron C, et al: Parameningeal rhabdomyosarcoma in pediatric age: Results of a pooled analysis from North American and European cooperative groups. Ann Oncol 25: 231-236, 2014
5. Breneman J, Meza J, Donaldson SS, et al: Local control with reduced-dose radiotherapy for low-risk rhabdomyosarcoma: A report from the Children's Oncology Group D9602 study. Int J Radiat Oncol Biol Phys 83:720-726, 2012
6. Minn AY, Lyden ER, Anderson JR, et al: Early treatment failure in intermediate-risk rhabdomyosarcoma: Results from IRS-IV and D9803-A report from the Children's Oncology Group. J Clin Oncol 28:4228-4232, 2010
7. Wolden SL, Anderson JR, Crist WM, et al: Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Studies I to III. J Clin Oncol 17:3468-3475, 1999
8. Miralbell R, Lomax A, Cella L, et al: Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors. Int J Radiat Oncol Biol Phys 54:824-829, 2002
9. Cotter SE, McBride SM, Yock TI: Proton radiotherapy for solid tumors of childhood. Technol Cancer Res Treat 11:267-278, 2012
10. Kozak KR, Adams J, Krejcarek SJ, et al: A dosimetric comparison of proton and intensitymodulated photon radiotherapy for pediatric parameningeal rhabdomyosarcomas. Int J Radiat Oncol Biol Phys 74:179-186, 2009
11. Yock T, Schneider R, Friedmann A, et al: Proton radiotherapy for orbital rhabdomyosarcoma: Clinical outcome and a dosimetric comparison with photons. Int J Radiat Oncol Biol Phys 63:1161-1168, 2005
12. Childs SK, Kozak KR, Friedmann AM, et al: Proton radiotherapy for parameningeal rhabdomyosarcoma: Clinical outcomes and late effects. Int J Radiat Oncol Biol Phys 82:635-642, 2012
13. Cotter SE, Herrup D.A., Friedmann A, et al: Proton radiotherapy for pediatric bladder/prostate rhabdomyosarcoma: Clinical outcomes and dosimetry compared to intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 81:1367-1373, 2011
14. Paganetti H, Niemierko A, Ancukiewicz M, et al: Relative biological effectiveness (RBE) values for proton beam therapy. Int J Radiat Oncol Biol Phys 53:407-421, 2002
15. Pappo AS, Lyden E, Breitfeld P, et al: Two consecutive phase II window trials of irinotecan alone or in combination with vincristine for the treatment of metastatic rhabdomyosarcoma: The Children's Oncology Group. J Clin Oncol 25:362-369, 2007
16. Spalding AC, Hawkins DS, Donaldson SS, et al: The effect of radiation timing on patients with high-risk features of parameningeal rhabdomyosarcoma: An analysis of IRS-IV and D9803. Int J Radiat Oncol Biol Phys 87:512-516, 2013
17. Yang JC, Wexler LH, Meyers PA, et al: Parameningeal rhabdomyosarcoma: Outcomes and opportunities. Int J Radiat Oncol Biol Phys 85:e61-e66, 2013
18. Eaton BR, McDonald MW, Kim S, et al: Radiation therapy target volume reduction in pediatric rhabdomyosarcoma: Implications for patterns of disease recurrence and overall survival. Cancer 119: 1578-1585, 2013
19. Curtis AE, Okcu MF, Chintagumpala M, et al: Local control after intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma. Int J Radiat Oncol Biol Phys 73:173-177, 2009
20. Pappo AS, Meza JL, Donaldson SS, et al: Treatment of localized nonorbital, nonparameningeal head and neck rhabdomyosarcoma: Lessons learned from Intergroup Rhabdomyosarcoma Studies III and IV. J Clin Oncol 21:638-645, 2003
21. Crist WM, Anderson JR, Meza JL, et al: Intergroup Rhabdomyosarcoma Study-IV: Results for patients with nonmetastatic disease. J Clin Oncol 19:3091-3102, 2001
22. Arndt C, Rodeberg D, Breitfeld PP, et al: Does bladder preservation (as a surgical principle) lead to retaining bladder function in bladder/prostate rhabdomyosarcoma? Results from Intergroup Rhabdomyosarcoma Study IV. J Urol 171:2396-2403, 2004
23. Casey DL, Wexler LH, LaQuaglia MP, et al: Patterns of failure for rhabdomyosarcoma of the perineal and perianal region. Int J Radiat Oncol Biol Phys 89:82-87, 2014
24. Blakely ML, Andrassy RJ, Raney RB, et al: Prognostic factors and surgical treatment guidelines for children with rhabdomyosarcoma of the perineum or anus: A report of Intergroup Rhabdomyosarcoma Studies I through IV, 1972 through 1997. J Pediatr Surg 38:347-353, 2003
25. Neville HL, Andrassy RJ, Lobe TE, et al: Preoperative staging, prognostic factors, and outcome for extremity rhabdomyosarcoma: A preliminary report from the Intergroup Rhabdomyosarcoma Study IV (1991-1997). J Pediatr Surg 35:317-321, 2000
26. Donaldson SS, Meza J, Breneman JC, et al: Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma-A report from the IRSG. Int J Radiat Oncol Biol Phys 51:718-728, 2001
27. Combs SE, Behnisch W, Kulozik AE, et al: Intensity Modulated Radiotherapy (IMRT) and Fractionated Stereotactic Radiotherapy (FSRT) for children with head-and-neck-rhabdomyosarcoma. BMC Cancer 7:177, 2007
28. Raney RB, Asmar L, Vassilopoulou-Sellin R, et al: Late complications of therapy in 213 children with localized, nonorbital soft-tissue sarcoma of the head and neck: A descriptive report from the Intergroup Rhabdomyosarcoma Studies (IRS)-II and-III-IRS Group of the Children's Cancer Group and the Pediatric Oncology Group. Med Pediatr Oncol 33: 362-371, 1999
29. Raney RB, Anderson JR, Kollath J, et al: Late effects of therapy in 94 patients with localized rhabdomyosarcoma of the orbit: Report from the Intergroup Rhabdomyosarcoma Study (IRS)-III, 1984-1991. Med Pediatr Oncol 34:413-420, 2000
30. Wolden SL, Wexler LH, Kraus DH, et al: Intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma. Int J Radiat Oncol Biol Phys 61:1432-1438, 2005
31. Chung CS, Yock TI, Nelson K, et al: Incidence of second malignancies among patients treated with proton versus photon radiation. Int J Radiat Oncol Biol Phys 87:46-52, 2013